Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

Sublingual versus subcutaneous buprenorphine in opiate abusers.

Jasinski DR, Fudala PJ, Johnson RE.

Clin Pharmacol Ther. 1989 May;45(5):513-9.

PMID:
2721107
[PubMed - indexed for MEDLINE]
2.

Buprenorphine in the treatment of opiate dependence: its pharmacology and social context of use in the U.S.

Wesson DR.

J Psychoactive Drugs. 2004 May;Suppl 2:119-28. Review.

PMID:
15279124
[PubMed - indexed for MEDLINE]
3.

Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

Mendelson J, Jones RT.

Drug Alcohol Depend. 2003 May 21;70(2 Suppl):S29-37. Review.

PMID:
12738348
[PubMed - indexed for MEDLINE]
4.

Behavioral pharmacology of buprenorphine: issues relevant to its potential in treating drug abuse.

Woods JH, France CP, Winger GD.

NIDA Res Monogr. 1992;121:12-27. Review. No abstract available.

PMID:
1406907
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk